Robert Nelsen - Insider Trading & Ownership

Entity
Individual
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated net worth of Robert Nelsen is at least $432M dollars as of June 17, 2024. Robert Nelsen is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $178M. Robert Nelsen is the Director, 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $96.7M. Robert Nelsen is the Director, 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $83M. Robert Nelsen is the Director, 10%+ Owner of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $68.5M. Robert Nelsen is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $5.87M.
All Insider Reports
All Insider Reports

Ownership of Robert Nelsen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $178M Jun 2, 2021
PRME Prime Medicine, Inc. Director, 10%+ Owner $96.7M +$20M +26.1% Jun 12, 2024
LYEL Lyell Immunopharma, Inc. Director, 10%+ Owner $83M Jun 14, 2024
SANA Sana Biotechnology, Inc. Director, 10%+ Owner $68.5M +$10M +17.1% Jun 6, 2024
VIR Vir Biotechnology, Inc. Director $5.87M May 30, 2024

Insider Transactions Reported by Robert Nelsen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.